DTx: Don’t Set a Bad Precedent

One article in my series about Digital Therapeutics after interviews with CEOs in the new category.

A huge worry by CEOs is what other companies will do in their quest for adoption, how they commercialize, agreements they might make. The concern is what precedents might be set that could affect other companies.

More people need to align to a solutions oriented commercial approach when talking with payers, providers, and patients. Everyone is looking for solutions to clinical and economic problems. For every product that is added into the system, someone wants something taken out. Finding the unmet clinical and economic needs should be the primary concern.

If leaders in the category will agree to focus on solutions with customers, everyone would avoid mistakes that could adversely affect the category and cause a loss of credibility.

Using commercialization strategies that have been proven with pharmaceuticals or medical devices will ensure you aren’t setting yourself up for failure or hurting your credibility or the credibility of the category through an unintended mistake. Let’s discuss how to set your company up for sustainable success.